Skip to content

Nasdaq · CIK 0001677940

BYSI BeyondSpring Inc.

Insider trading from SEC Form 4. Last filing Jul 6, 2026. Close $0.61 on Oct 9, 2026, +1% from the 52-week low and -74% from the high.

In brief

BeyondSpring Inc. (BYSI) has 34 SEC Form 4 filings on file from 9 insiders, the latest filed on Jul 6, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

17 open-market trades have been scored at BYSI. The newest: Decheng Capital China Life Sciences USD Fund III, L.P. (10% owner) sold $228k of stock on Oct 16, 2025, filed Oct 20, 2025, scored 25 (weak). The largest of the 17 shown: Decheng Capital China Life Sciences USD Fund III, L.P. (10% owner) sold $1.2M on Jun 17, 2025, scored 47 (moderate).

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company

Price and insider trades, last year

BYSIOct 9, 2026 · close 0.61

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at BeyondSpring Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
25WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$228k
131,311 shares
-8%-
25WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$259k
153,816 shares
-9%-
12WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$25k
13,876 shares
-1%-
18WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$36k
20,200 shares
-1%-
12WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$14k
7,665 shares
-0%-
12WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$3,045
1,800 shares
-0%-
12WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$21k
11,772 shares
-1%-
12WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$20k
11,267 shares
-1%-
12WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$7,603
4,110 shares
-0%-
18WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$41k
21,046 shares
-1%-
12WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$17k
8,999 shares
-0%-
12WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$8,675
4,870 shares
-0%-
12WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$7,358
4,109 shares
-0%-
12WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$10k
5,710 shares
-0%-
22WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$109k
54,728 shares
-3%-
12WeakDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$9,800
4,900 shares
-0%-
47ModerateDecheng Capital China Life Sciences USD Fund III, L.P.
owner
sell
$1.2M
394,436 shares
-39%-

Transactions

The newest 50 of 80 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Jul 1, 2026Min Qiu
Chief Executive Officer
AGrant or award
Stock Options (right to buy)derivative
+100,000$0.00$0100,000Jul 6, 2026
Jul 1, 2026Jiangwen Majeti
director
AGrant or award
Stock Options (right to buy)derivative
+100,000$0.00$0100,000Jul 6, 2026
Mar 20, 2026Lan Huang
Chief Executive Officer
GGift
Ordinary Sharesindirect: By Lan Huang 2022 Grantor Retained Annuity Trust
-260,582$0.00$00May 15, 2026
Apr 1, 2026Matthew Kirkby
director
AGrant or award
Stock Options (right to buy)derivative
+23,902$0.00$023,902Apr 8, 2026
Apr 1, 2026Sihai Xu
director
AGrant or award
Stock Options (right to buy)derivative
+18,689$0.00$018,689Apr 3, 2026
Apr 1, 2026Brendan Delaney
director
AGrant or award
Stock Options (right to buy)derivative
+20,427$0.00$020,427Apr 3, 2026
Apr 1, 2026Jiangwen Majeti
director
AGrant or award
Stock Options (right to buy)derivative
+21,730$0.00$021,730Apr 3, 2026
Apr 1, 2026Yingjuan June Lu
Chief Scientific Officer
AGrant or award
Stock Options (right to buy)derivative
+17,840$0.00$017,840Apr 3, 2026
Apr 1, 2026Lan Huang
Chief Executive Officer
AGrant or award
Stock Options (right to buy)derivative
+11,514$0.00$011,514Apr 3, 2026
Apr 1, 2026Patrick Fabbio
director
AGrant or award
Stock Options (right to buy)derivative
+22,165$0.00$022,165Apr 3, 2026
Oct 16, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-85,798$1.72$148k1,564,406Oct 20, 2025
Oct 17, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-45,513$1.76$80k1,518,893Oct 20, 2025
Oct 13, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-107,361$1.70$183k1,696,659Oct 15, 2025
Oct 14, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-28,495$1.65$47k1,668,164Oct 15, 2025
Oct 15, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-17,960$1.65$30k1,650,204Oct 15, 2025
Oct 8, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-7,507$1.77$13k1,810,389Oct 10, 2025
Oct 9, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-3,979$1.81$7,2021,806,410Oct 10, 2025
Oct 10, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-2,390$1.77$4,2301,804,020Oct 10, 2025
Oct 3, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-600$1.76$1,0561,837,496Oct 7, 2025
Oct 6, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-17,500$1.78$31k1,819,996Oct 7, 2025
Oct 7, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-2,100$1.79$3,7591,817,896Oct 7, 2025
Sep 30, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-4,464$1.81$8,0801,841,297Oct 2, 2025
Oct 1, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-2,601$1.80$4,6821,838,696Oct 2, 2025
Oct 2, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-600$1.73$1,0381,838,096Oct 2, 2025
Sep 25, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-700$1.66$1,1621,846,861Sep 29, 2025
Sep 26, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-600$1.68$1,0081,846,261Sep 29, 2025
Sep 29, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-500$1.75$8751,845,761Sep 29, 2025
Sep 22, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-5,410$1.83$9,9001,853,923Sep 24, 2025
Sep 23, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-4,106$1.72$7,0621,849,817Sep 24, 2025
Sep 24, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-2,256$1.68$3,7901,847,561Sep 24, 2025
Sep 17, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-2,304$1.83$4,2161,868,296Sep 19, 2025
Sep 18, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-5,307$1.74$9,2341,862,989Sep 19, 2025
Sep 19, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-3,656$1.79$6,5441,859,333Sep 19, 2025
Sep 12, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-700$1.85$1,2951,874,010Sep 16, 2025
Sep 15, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-2,570$1.84$4,7291,871,440Sep 16, 2025
Sep 16, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-840$1.88$1,5791,870,600Sep 16, 2025
Sep 9, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-9,050$1.97$18k1,886,706Sep 11, 2025
Sep 10, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-8,176$1.93$16k1,878,530Sep 11, 2025
Sep 11, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-3,820$1.90$7,2581,874,710Sep 11, 2025
Sep 4, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-803$1.82$1,4611,903,952Sep 8, 2025
Sep 5, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-1,106$1.86$2,0571,902,846Sep 8, 2025
Sep 8, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-7,090$1.93$14k1,895,756Sep 8, 2025
Aug 29, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-800$1.74$1,3921,908,825Sep 3, 2025
Sep 2, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-2,800$1.78$4,9841,906,025Sep 3, 2025
Sep 3, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-1,270$1.81$2,2991,904,755Sep 3, 2025
Aug 26, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-2,000$1.79$3,5801,911,734Aug 28, 2025
Aug 27, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-1,300$1.78$2,3141,910,434Aug 28, 2025
Aug 28, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-809$1.81$1,4641,909,625Aug 28, 2025
Aug 21, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-3,034$1.79$5,4311,916,410Aug 25, 2025
Aug 22, 2025Decheng Capital China Life Sciences USD Fund III, L.P.
owner
SOpen-market sale
Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P.
-2,376$1.75$4,1581,914,034Aug 25, 2025
50 of 80 rows shown.

Insiders

Everyone who has filed a Form 4 here.

Questions about BYSI

Answered from the filings on this page, as of the latest one.

Are insiders buying BYSI?

No. In the last 90 days no insider at BeyondSpring Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade BYSI on the open market?

Decheng Capital China Life Sciences USD Fund III, L.P. (10% owner) sold $228k of BYSI on Oct 16, 2025 and filed the Form 4 on Oct 20, 2025. InsiderTell scored 25 (weak).

How many insiders file Form 4 at BeyondSpring Inc.?

9 people have filed a Form 4 at BeyondSpring Inc., among them Decheng Capital China Life Sciences USD Fund III, L.P. (10% owner), Brendan Delaney (director), Patrick Fabbio (CFO and director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

BYSI insider trading: BeyondSpring Inc. | InsiderTell